NanoBio makes appointment
This article was originally published in Scrip
Executive Summary
NanoBio (US) has appointed Dr Daniel Dubin to its board of directors. He is vice-chairman and a director at Leerink Swann, a healthcare and biotechnology investment banking firm. NanoBio is a private biopharmaceutical company developing and commercialising anti-infective products and mucosal vaccines derived from its NanoStat technology platform.